-
Rimonabant in CB1 Withdrawal Research
2026-08-30
Rimonabant (SR141716) provides a selective CB1 challenge for separating cannabinoid-receptor mechanisms from locomotor and anxiety-related confounds. This workflow translates sex- and time-dependent findings from withdrawal research into practical assay design for appetite regulation research, obesity research, and broader endocannabinoid pharmacology.
-
Chloroquine Diphosphate in Ferroptosis Assays
2026-08-29
Learn how to deploy Chloroquine Diphosphate as an autophagy-flux control, TLR7/TLR9 inhibitor, and sensitization variable in AML and broader cancer research. This workflow connects DGLA–ACSL4 ferroptosis biology with practical assay design, controls, and troubleshooting.
-
Nitrocefin and the Next Wave of β-Lactamase Discovery
2026-08-28
Nitrocefin turns β-lactamase hydrolysis into a rapid, interpretable signal. This thought-leadership guide connects that chromogenic assay with structure-based peptide discovery, using recent TEM-1 inhibitor research to outline a more rigorous translational workflow for antibiotic resistance programs.
-
LDH Cytotoxicity Assay Kit: Practical Guide
2026-08-28
The LDH Cytotoxicity Assay Kit (SKU K2228) provides a non-radioactive, colorimetric approach to cell cytotoxicity measurement by detecting LDH released into culture medium after membrane damage. It is suitable for cultured-cell viability and damage studies, but should not be treated as a standalone apoptosis mechanism assay or applied to tissue samples without protocol adaptation.
-
Quercetin Workflows for PI3K and Ferroptosis Studies
2026-08-27
Use Quercetin as a multiparametric probe to connect PI3K signaling, mitochondrial apoptosis, ferroptosis, and inflammatory responses in cancer research. This workflow emphasizes solvent control, orthogonal readouts, and causal validation rather than relying on a single viability endpoint.
-
HotStart™ Universal 2X Green qPCR Guide
2026-08-27
Learn how HotStart Universal 2X Green qPCR Master Mix supports dosage-aware gene expression quantification in NEXMIF neurodevelopmental research. This guide connects hot-start chemistry, Green I fluorescence, melt curve analysis, and biologically informed assay design.
-
L-NMMA acetate for NO Pathway Research
2026-08-26
L-NMMA acetate enables controlled, pan-NOS inhibition for testing whether nitric oxide signaling drives cellular phenotypes rather than merely accompanying them. Its aqueous compatibility supports practical workflows spanning dental follicle osteogenesis, inflammation research, and exploratory cardiovascular disease research.
-
CCK-8 Workflow for ER-Stressed Macrophages
2026-08-26
Use CCK-8 to quantify how tunicamycin, ER-stress inhibitors, or candidate compounds alter macrophage metabolic viability in a reproducible microplate workflow. The assay’s water-soluble formazan simplifies screening, while careful calibration and orthogonal death readouts prevent metabolic changes from being mistaken for cell-number changes.
-
Hydrocortisone Workflows for Rapid Cell Signaling
2026-08-25
Hydrocortisone supports controlled studies of glucocorticoid receptor signaling, acute neuronal calcium dynamics, barrier protection, and inflammation. This workflow-centered guide connects rapid live-cell assays with longer-term disease models while emphasizing solubility, timing, controls, and troubleshooting.
-
Go 6983 (pan-PKC inhibitor) Workflow Guide
2026-08-25
Build reproducible PKC pathway, EMT, cancer, and developmental-model assays with Go 6983 while separating acute signaling effects from long-term phenotypes. This guide combines formulation guidance, quantified pilot conditions, metabolism-aware readouts, and troubleshooting for more defensible mechanistic conclusions.
-
Pam3CSK4 TFA for TLR1/2 Immune Profiling
2026-08-24
Pam3CSK4 TFA enables controlled TLR1/2 agonism for dissecting cytokine competence rather than merely measuring inflammation. This article translates maternal–neonatal GBS findings into a rigorous assay strategy for mechanistic innate-immunity research.
-
PSA-CD56/Siglec-7 Immune Evasion in ccRCC
2026-08-24
A 2026 study identifies polysialylated CD56 as a glyco-immune checkpoint that engages Siglec-7 on CD8 T cells in clear cell renal cell carcinoma. The findings connect tumor-associated glycosylation with impaired cytokine production, T-cell apoptosis, immune exclusion, and resistance to immunotherapy, while supporting PSA-CD56 or Siglec-7 blockade as a mechanistically grounded intervention.
-
Cy5 TSA Fluorescence System Kit Guide
2026-08-22
A scenario-driven guide to using the Cy5 TSA Fluorescence System Kit, SKU K1052, for sensitive target detection in ICC, IHC, and FISH workflows. It explains HRP-mediated tyramide deposition, protocol parameters, controls, interpretation, and practical vendor-selection criteria for cell biology laboratories.
-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-08-22
Track where an mRNA goes with Cy5, then measure what it produces with Firefly Luciferase in the same experiment. This dual-readout design helps separate delivery failure from translation failure during formulation screening, intracellular trafficking studies, and in vivo imaging development.
-
AptaBLE: Deep Learning for Aptamer Design
2026-08-21
AptaBLE is a sequence-based deep learning platform that combines pretrained protein and nucleic acid encoders with symmetric bidirectional cross-attention to predict aptamer–protein binding. The preprint reports improved binding-prediction performance and de novo aptamer generation with reported Kd values as low as 31 nM, while highlighting the need for experimental validation.